Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With Relapsing-remitting and Secondary-progressive Multiple Sclerosis

NCT00463710 is registered in ClinicalTrials.gov with State University of New York at Buffalo as lead sponsor.

NCT NCT00463710
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00463710 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effect of Interferon Beta-1a (Avonex®) on Changes of Non-conventional MRI Measures in Patients With Relapsing-remitting and Secondary-progressive Multiple Sclerosis
Lead sponsor
State University of New York at Buffalo
Phase
Observational
Overall status
Completed
Start date
June 30, 2005
Completion date
September 30, 2006
Enrollment
150
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

multiple sclerosis